Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.

Publikation

Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.

Wissenschaftlicher Artikel/Review - 21.09.2017

Bredell Marius, Rordorf Tamara, Kroiss Sabine, Rücker Martin, Zweifel Daniel Fritz, Rostetter Claudio

Zitation

Bredell M, Rordorf T, Kroiss S, Rücker M, Zweifel D, Rostetter C. Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. J Oral Maxillofac Surg 2017; 76:775-784.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Oral Maxillofac Surg 2017; 76

Veröffentlichungsdatum

21.09.2017

eISSN (Online)

1531-5053

Seiten

775-784

Kurzbeschreibung/Zielsetzung

Giant cell granuloma (GCG) of the jaw is a rare disease with high morbidity. Various treatment options have been discussed in the past. Since 2010, a pharmaceutical therapy with denosumab seems to have been successful for giant cell tumors of the femur. The authors hypothesized the equally successful use of denosumab for GCGs of the jaws.